KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Invested Capital (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 17 years of Invested Capital data on record, last reported at $1.2 billion in Q3 2025.

  • For Q3 2025, Invested Capital rose 76.66% year-over-year to $1.2 billion; the TTM value through Sep 2025 reached $1.2 billion, up 76.66%, while the annual FY2024 figure was $588.4 million, 36.5% up from the prior year.
  • Invested Capital reached $1.2 billion in Q3 2025 per IONS's latest filing, down from $1.3 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $1.3 billion in Q2 2025 and bottomed at $308.1 million in Q2 2024.
  • Average Invested Capital over 5 years is $621.5 million, with a median of $592.5 million recorded in 2021.
  • Peak YoY movement for Invested Capital: plummeted 61.19% in 2021, then surged 309.53% in 2025.
  • A 5-year view of Invested Capital shows it stood at $775.3 million in 2021, then dropped by 26.1% to $572.9 million in 2022, then dropped by 24.76% to $431.0 million in 2023, then skyrocketed by 36.5% to $588.4 million in 2024, then soared by 112.27% to $1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $1.2 billion in Q3 2025, $1.3 billion in Q2 2025, and $475.7 million in Q1 2025.